Hunter Gillies - Net Worth and Insider Trading

Hunter Gillies Net Worth

The estimated net worth of Hunter Gillies is at least $112,992 dollars as of 2024-05-21. Hunter Gillies is the CHIEF MEDICAL OFFICER of Aerovate Therapeutics Inc and owns about 5,602 shares of Aerovate Therapeutics Inc (AVTE) stock worth over $112,992. Details can be seen in Hunter Gillies's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Hunter Gillies has not made any transactions after 2024-05-17 and currently still holds the listed stock(s).

Transaction Summary of Hunter Gillies

To

Hunter Gillies Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Hunter Gillies owns 1 companies in total, including Aerovate Therapeutics Inc (AVTE) .

Click here to see the complete history of Hunter Gillies’s form 4 insider trades.

Insider Ownership Summary of Hunter Gillies

Ticker Comapny Transaction Date Type of Owner
AVTE Aerovate Therapeutics Inc 2024-05-17 Chief Medical Officer

Hunter Gillies Latest Holdings Summary

Hunter Gillies currently owns a total of 1 stock. Hunter Gillies owns 5,602 shares of Aerovate Therapeutics Inc (AVTE) as of May 17, 2024, with a value of $112,992.

Latest Holdings of Hunter Gillies

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AVTE Aerovate Therapeutics Inc 2024-05-17 5,602 20.17 112,992

Holding Weightings of Hunter Gillies


Hunter Gillies Form 4 Trading Tracker

According to the SEC Form 4 filings, Hunter Gillies has made a total of 14 transactions in Aerovate Therapeutics Inc (AVTE) over the past 5 years, including 0 buys and 14 sells. The most-recent trade in Aerovate Therapeutics Inc is the sale of 4,000 shares on May 17, 2024, which brought Hunter Gillies around $84,320.

Insider Trading History of Hunter Gillies

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Hunter Gillies Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Hunter Gillies Ownership Network

Ownership Network List of Hunter Gillies

No Data

Ownership Network Relation of Hunter Gillies


Hunter Gillies Owned Company Details

What does Aerovate Therapeutics Inc do?

Who are the key executives at Aerovate Therapeutics Inc?

Hunter Gillies is the Chief Medical Officer of Aerovate Therapeutics Inc. Other key executives at Aerovate Therapeutics Inc include director & Chief Executive Officer Timothy P Noyes , SENIOR VICE PRESIDENT & CMC Marinus Verwijs , and See Remarks Benjamin T Dake .

Aerovate Therapeutics Inc (AVTE) Insider Trades Summary

Over the past 18 months, Hunter Gillies made 14 insider transaction in Aerovate Therapeutics Inc (AVTE) with a net sale of 62,255. Other recent insider transactions involving Aerovate Therapeutics Inc (AVTE) include a net sale of 235,587 shares made by Benjamin T Dake , a net sale of 153,142 shares made by Timothy P Noyes , and a net sale of 45,600 shares made by Ralph Niven .

In summary, during the past 3 months, insiders sold 209,036 shares of Aerovate Therapeutics Inc (AVTE) in total and bought 0 shares, with a net sale of 209,036 shares. During the past 18 months, 612,771 shares of Aerovate Therapeutics Inc (AVTE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 612,771 shares.

Aerovate Therapeutics Inc (AVTE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Aerovate Therapeutics Inc Insider Transactions

No Available Data

Hunter Gillies Mailing Address

Above is the net worth, insider trading, and ownership report for Hunter Gillies. You might contact Hunter Gillies via mailing address: C/o Aerovate Therapeutics, Inc., 200 Berkeley Street, Floor 18, Boston Ma 02116.

Discussions on Hunter Gillies

No discussions yet.